warhead
-
Novo and Eli Lilly’s favored ADC payload, are you interested? | DrugTimes BD Project
If your company is interested in the new NMTi payload, please contact DrugTimes BD team as soon as possible!
If your company is interested in the new NMTi payload, please contact DrugTimes BD team as soon as possible!
